Updated:
Penumbra Inc
Penumbra develops thrombectomy and neurovascular devices. Its July 2026 results described a pending Boston Scientific acquisition.
Overview
Penumbra develops medical technologies for conditions including ischemic stroke, venous thromboembolism and acute limb ischemia. Its portfolio includes thrombectomy, embolization and access technologies. It sells to healthcare providers through direct sales teams and distributors in international markets. Its PEN shares trade on NYSE. Its reported principal executive office is in Alameda, CA, United States. For the fiscal year ended 2025-12-31, the originally reported results include revenue of USD 1,403,665,000; net income of USD 177,687,000; operating cash flow of USD 238,663,000. At that year-end, its balance sheet reports total assets of USD 1,826,519,000 and cash and cash equivalents of USD 186,897,000. Penumbra entered a merger agreement with Boston Scientific on January 14, 2026. In its July 30, 2026 results, it described the acquisition as pending and withheld full-year 2026 financial guidance because of the proposed transaction.
Company overview
- Legal name
- Penumbra Inc
- Classification
- Public company
- Industry (SIC)
- 3841 — Surgical & Medical Instruments & Apparatus
- Headquarters
- Alameda, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- Ticker
- NYSE: PEN
- SEC CIK
- 0001321732
- Website
- www.penumbrainc.com
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2025USD | $1.4B | $177.7M | $1.8B | $186.9M | $238.7M | |
| FY2024USD | $1.2B | $14.0M | $1.5B | $324.4M | $168.5M | |
| FY2023USD | $1.1B | $91.0M | $1.6B | $167.5M | $97.3M | |
| FY2022USD | $847.1M | -$2.0M | $1.4B | $69.9M | -$55.7M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| DEF 14A | DEF 14A | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Penumbra Inc in Altss
Track this company’s investors, transactions and relationships in Altss.